INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

76,380 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
35
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$67K
5,329 sh
Jun 2, 2026Jun 3, 2026
Page 868 of 1910
← PrevNext →
traded Jun 2, 2026
+1d
SEC Form 4

Evidence

35
RJ
Russell Steven JonChief Medical Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$53K
4,222 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

35
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$84K
6,676 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

34
KJ
Kim Peter Sung-JipSVP & GM Industrial Business
LFUSLITTELFUSE INC /DE
Open-market sale
SELL$4.91M
10.1K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

34
Josh GottheimerDJoint
SNDKSandisk Corp
Purchase
BUY$1,001 – $15KMay 7, 2026Jun 3, 2026
traded May 7, 2026
+27dHouse PTR

Evidence

34
Josh GottheimerDJoint
MUMICRON TECHNOLOGY INC
Purchase
BUY$1,001 – $15KMay 21, 2026Jun 3, 2026
traded May 21, 2026
+13dHouse PTR

Evidence

34
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Open-market sale
SELL$59K
7,679 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

32
FM
Fruhbeis Todd MichaelDirector
STRRStar Equity Holdings, Inc.
Open-market purchase
BUY$8,204
700 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

32
CT
Chuang Patrick T.Senior VP, Memory Design
GSITGSI TECHNOLOGY INC
Open-market sale
SELL$439K
40.0K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

31
Tim WalbergRJoint
FSSLFS Specialty Lending Fund
Sale
SELL$15K – $50KJun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dHouse PTR

Evidence

31
Josh GottheimerDJoint
PANWPalo Alto Networks Inc
Purchase
BUY$1,001 – $15KMay 14, 2026Jun 3, 2026
traded May 14, 2026
+20dHouse PTR

Evidence

31
RC
Rivera CathrynChief Operating Officer
CDZICADIZ INC
Open-market sale
SELL$11K
2,500 sh
May 20, 2026Jun 3, 2026
traded May 20, 2026
+14dSEC Form 4

Evidence

31
NC
Nueno CarlosPresident, International
TDOCTeladoc Health, Inc.
Open-market sale
SELL$47K
6,196 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

29
Josh GottheimerDJoint
FNFabrinet
Purchase
BUY$1,001 – $15KMay 1, 2026Jun 3, 2026
traded May 1, 2026
+33dHouse PTR

Evidence

28
AA
Alkarmi AshrafDirector, Co-CEO
DBXDROPBOX, INC.
Open-market sale
SELL$632K
22.7K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

28
WJ
Wyrick JasonEVP, Technology
STRZSTARZ ENTERTAINMENT CORP /CN/
Open-market sale
SELL$71K
2,803 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

27
BD
Bender Bradley DChief Risk Officer
TFCTRUIST FINANCIAL CORP
Tax withholding
F$427K
9,115 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

26
Josh GottheimerDJoint
INTUINTUIT INC.
Partial sale
SELL$1,001 – $15KMay 22, 2026Jun 3, 2026
traded May 22, 2026
+12dHouse PTR

Evidence

26
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$53K
15.0K sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC Form 4

Evidence

25
Josh GottheimerDJoint
ABTABBOTT LABORATORIES
Partial sale
SELL$1,001 – $15KMay 27, 2026Jun 3, 2026
traded May 27, 2026
+7dHouse PTR

Evidence

25
Josh GottheimerDJoint
TPHTri Pointe Homes, Inc. Common Stock
Sale
SELL$1,001 – $15KMay 15, 2026Jun 3, 2026
traded May 15, 2026
+19dHouse PTR

Evidence

25
Cleo FieldsDSelf
AAPLApple Inc.
Purchase
BUY$1,001 – $15KMay 14, 2026Jun 3, 2026
traded May 14, 2026
+20dHouse PTR

Evidence

24
Josh GottheimerDJoint
LITELumentum Holdings Inc.
Purchase
BUY$1,001 – $15KMay 22, 2026Jun 3, 2026
traded May 22, 2026
+12dHouse PTR

Evidence

24
Josh GottheimerDJoint
ADIANALOG DEVICES INC
Purchase
BUY$1,001 – $15KMay 19, 2026Jun 3, 2026
traded May 19, 2026
+15dHouse PTR

Evidence

24
Josh GottheimerDJoint
TWLOTWILIO INC
Purchase
BUY$1,001 – $15KMay 4, 2026Jun 3, 2026
traded May 4, 2026
+30dHouse PTR

Evidence

23
CT
Chuang Patrick T.Senior VP, Memory Design
GSITGSI TECHNOLOGY INC
Option exercise
M$290K
40.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

23
KM
Klossner MarkEVP and Pres. IPS*
RRXREGAL REXNORD CORP
Grant or award
A$300K
1,484 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

22
HA
Heino Mary AnneDirector, Executive Chair and CEO
LNTHLantheus Holdings, Inc.
Tax withholding
F$119K
1,227 sh
May 14, 2026Jun 3, 2026
traded May 14, 2026
+20dSEC Form 4

Evidence

22
HK
Haynes Larry KDirector
CACCAMDEN NATIONAL CORP
Other acquisition or disposition
J—
3,218 sh
May 11, 2026Jun 3, 2026
traded May 11, 2026
+23dSEC Form 4

Evidence

22
HK
Haynes Larry KDirector
CACCAMDEN NATIONAL CORP
Other acquisition or disposition
J—
3,218 sh
May 11, 2026Jun 3, 2026
traded May 11, 2026
+23dSEC Form 4

Evidence

21
GR
Gaugh David RussellDirector
AMPHAmphastar Pharmaceuticals, Inc.
Grant or award
A—
8,143 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
EP
Evans Kimberly PetersonGeneral Counsel
BZAIBlaize Holdings, Inc.
Option exercise
M—
75.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
KR
Kapoor Rohit (RK2)Managing Director, Sinagpore
TNKTEEKAY TANKERS LTD.
Option exercise
M—
697 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

21
DA
deBeers Kimberly A.Director
ACIWACI WORLDWIDE, INC.
Grant or award
A—
5,720 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence

21
RC
Rogers ChrisDirector, President and CEO
CARTMaplebear Inc.
Open-market sale · 10b5-1 plan
SELL$321K
7,893 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
GM
Garcia David MichaelSr. VP of Finance
CVCapsoVision, Inc
Grant or award
A—
92.2K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
SS
Semel ScottInterim CLO & General Counsel
SKILSkillsoft Corp.
Option exercise
M—
4,000 sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
WH
Wang Kang-HuaiDirector, See Remarks
CVCapsoVision, Inc
Grant or award
A—
358.3K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$339K
13.3K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC Form 4

Evidence

21
SM
Seidelin MikkelChief Commercial Officer
TNKTEEKAY TANKERS LTD.
Option exercise
M—
2,323 sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC Form 4

Evidence